[go: up one dir, main page]

DE602004000016D1 - Schnell freisetzende farmazeutische darreichungsform enthaltend polymorphes tibolon - Google Patents

Schnell freisetzende farmazeutische darreichungsform enthaltend polymorphes tibolon

Info

Publication number
DE602004000016D1
DE602004000016D1 DE602004000016T DE602004000016T DE602004000016D1 DE 602004000016 D1 DE602004000016 D1 DE 602004000016D1 DE 602004000016 T DE602004000016 T DE 602004000016T DE 602004000016 T DE602004000016 T DE 602004000016T DE 602004000016 D1 DE602004000016 D1 DE 602004000016D1
Authority
DE
Germany
Prior art keywords
farmaceutical
tibolon
polymorphes
form containing
pharmaceutical form
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE602004000016T
Other languages
English (en)
Other versions
DE602004000016T2 (de
Inventor
Haan Pieter De
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Organon NV
Original Assignee
Akzo Nobel NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=33442854&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE602004000016(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Akzo Nobel NV filed Critical Akzo Nobel NV
Publication of DE602004000016D1 publication Critical patent/DE602004000016D1/de
Application granted granted Critical
Publication of DE602004000016T2 publication Critical patent/DE602004000016T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physical Education & Sports Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE602004000016T 2003-05-23 2004-05-19 Schnell freisetzende farmazeutische darreichungsform enthaltend polymorphes tibolon Expired - Lifetime DE602004000016T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP03101500 2003-05-23
EP03101500 2003-05-23
PCT/EP2004/050852 WO2004103378A1 (en) 2003-05-23 2004-05-19 Immediate-release pharmaceutical dosage form comprising polymorphous tibolone

Publications (2)

Publication Number Publication Date
DE602004000016D1 true DE602004000016D1 (de) 2005-07-07
DE602004000016T2 DE602004000016T2 (de) 2005-11-03

Family

ID=33442854

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004000016T Expired - Lifetime DE602004000016T2 (de) 2003-05-23 2004-05-19 Schnell freisetzende farmazeutische darreichungsform enthaltend polymorphes tibolon

Country Status (16)

Country Link
US (1) US20060134191A1 (de)
EP (1) EP1499278B1 (de)
JP (1) JP2006514996A (de)
KR (2) KR20050038590A (de)
AT (1) ATE296606T1 (de)
AU (1) AU2004203420B8 (de)
CA (1) CA2473718A1 (de)
DE (1) DE602004000016T2 (de)
DK (1) DK1499278T3 (de)
ES (1) ES2243919T3 (de)
MX (1) MXPA05000824A (de)
NZ (1) NZ534446A (de)
PL (1) PL1499278T3 (de)
PT (1) PT1499278E (de)
WO (1) WO2004103378A1 (de)
ZA (1) ZA200406042B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE344020T1 (de) * 2004-02-06 2006-11-15 Helm Ag Pharmazeutische zubereitungen mit amorphem tibolon
CN101835508A (zh) * 2007-10-25 2010-09-15 诺瓦提斯公司 单位剂量药物包装的粉末调节
KR101361244B1 (ko) * 2012-02-23 2014-02-11 박현석 무선 메시지를 이용한 문서 전송 시스템 및 방법
US10139090B2 (en) * 2015-11-02 2018-11-27 Joseph Goodrich Rechargeable illuminating shoes

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE665514A (de) * 1964-06-16
FR2408345A1 (fr) * 1976-11-30 1979-06-08 Besins Jean Louis Nouvelle composition a action anti-conceptionnelle
US4701450A (en) * 1984-03-21 1987-10-20 Akzo N.V. Steroids for use as immunomodulators
IE63051B1 (en) * 1989-03-18 1995-03-22 Akzo Nv Pharmaceutical composition which contains a pharmaceutically suitable carrier and the compound having the structure (7alpha, 17alpha)-17-Hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn- 3-one
IL123984A (en) * 1997-04-22 2004-09-27 Akzo Nobel Nv Pharmacological dosage units containing tibolone and carrier pharmacy are acceptable
US6761903B2 (en) * 1999-06-30 2004-07-13 Lipocine, Inc. Clear oil-containing pharmaceutical compositions containing a therapeutic agent
NZ534348A (en) * 2000-01-28 2006-06-30 Endorech Inc Selective estrogen receptor modulators in combination with estrogens
ES2284946T3 (es) * 2001-10-18 2007-11-16 Norton Healthcare Limited Formulaciones de tibolona.

Also Published As

Publication number Publication date
KR20050038590A (ko) 2005-04-27
AU2004203420B2 (en) 2008-01-31
PL1499278T3 (pl) 2005-09-30
ZA200406042B (en) 2006-05-31
US20060134191A1 (en) 2006-06-22
PT1499278E (pt) 2005-08-31
MXPA05000824A (es) 2005-04-28
CA2473718A1 (en) 2004-11-23
KR20060028822A (ko) 2006-04-03
WO2004103378A1 (en) 2004-12-02
EP1499278B1 (de) 2005-06-01
EP1499278A1 (de) 2005-01-26
AU2004203420A1 (en) 2004-12-02
AU2004203420B8 (en) 2008-02-21
DE602004000016T2 (de) 2005-11-03
JP2006514996A (ja) 2006-05-18
ATE296606T1 (de) 2005-06-15
DK1499278T3 (da) 2005-10-03
NZ534446A (en) 2007-03-30
ES2243919T3 (es) 2005-12-01

Similar Documents

Publication Publication Date Title
DK0954314T3 (da) Doseringsformer til bedring af mandlig erektionsdefekt
BG66093B1 (bg) Състави с контролирано освобождаване, съдържащи нимесулид
EA200801926A1 (ru) Таблетки парацетамола с быстрым высвобождением
NO20076613L (no) Farmasoytiske formuleringer og anvendelse derav
EA200501586A1 (ru) Фармацевтические продукты
AU2003274681A1 (en) Dosage form comprising high dose high soluble active ingredient as modified release and low dose active ingredient as immediate release
AR035500A1 (es) Uso de clorpromazina y pentamidina para la fabricacion de medicamentos, composicion farmaceutica y paquete farmaceutico que comprenden clorpromazina y pentamidina.
DE60321386D1 (de) Pharmazeutische zubereitung zur modifizierten freisetzung
DE60102590D1 (de) Darreichungsformen zur behandlung von oralen mykosen
NO20060445L (no) Fast farmasoytisk preparat omfattende amisulprid
ATE304844T1 (de) Entzündungshemmende pharmazeutische formulierungen
ES2189739T3 (es) Composiciones de betahistina de liberacion controlada.
DE602004000016D1 (de) Schnell freisetzende farmazeutische darreichungsform enthaltend polymorphes tibolon
DE602004014964D1 (de) Pharmazeutische zusammensetzung mit einem kationischen hilfsmittel
DE60111503D1 (de) Pharmazeutische zusammensetzungen enthaltend terbinafin
AR034142A1 (es) Una composicion farmaceutica, metodo para fabricar un medicamento en base a dicha composicion y uso de la composicion
ZA200506992B (en) Fibrate tablet and method for the production thereof
MY141008A (en) Oral formulations of deoxypeganine and their uses
IS7383A (is) Skammtaform með stýrða lyflosun til inngjafar
DE60211916D1 (de) Synergistische füllzusammensetzung
BR0311209A (pt) Método de produção de unidades de dosagem farmacêuticas para administração oral, uso de etonogestrel, e, tablete
SV2006002224A (es) Composicion farmaceutica ref. bhco41368-sv
IL162769A0 (en) Tibolone in the treatment of complaints associatedwith the administration of drugs which prevent thesynthesis of endogenousestrogen
ECSP982396A (es) Composiciones que contienen tetrahidrolipstatina
HK1070286A (en) Immediate-release pharmaceutical dosage form comprising polymorphous tibolone

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: N.V. ORGANON, OSS, NL

R082 Change of representative

Ref document number: 1499278

Country of ref document: EP

Representative=s name: WUESTHOFF & WUESTHOFF PATENT- UND RECHTSANWAEL, DE